# Changes in Insulin Resistance in Healthy Volunteers on STRIBILD® Medication

> **NCT02203461** · PHASE1 · COMPLETED · sponsor: **Technical University of Munich** · enrollment: 30 (actual)

## Conditions studied

- Insulin Resistance

## Interventions

- **DRUG:** Tenofovir disaproxil fumarate/emtricitabine/elvitegravir/cobicistat
- **DRUG:** Tenofovir disaproxil fumarate/emtricitabine + Lopinavir/ritonavir
- **DRUG:** Tenofovir disaproxil fumarate/emtricitabine + ritonavir-boosted darunavir

## Key facts

- **NCT ID:** NCT02203461
- **Lead sponsor:** Technical University of Munich
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2014-10
- **Final completion:** 2014-10
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2014-11-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02203461

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02203461, "Changes in Insulin Resistance in Healthy Volunteers on STRIBILD® Medication". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02203461. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*